Brief: Catalyst Biosciences Announces Withdrawal Of JDS1 Nominations To Board
Aug 10 (Reuters) - Catalyst Biosciences Inc CBIO.O :
* CATALYST BIOSCIENCES ANNOUNCES WITHDRAWAL OF JDS1
NOMINATIONS TO
THE BOARD
* CATALYST - JDS1 HAS WITHDRAWN NOMINATIONS OF SHELLY C.
LOMBARD,
MATTHEW STECKER, AND IGOR VOLSHTEY FOR ELECTION TO BOARD AT 2022
ANNUAL MEETING
Source text for Eikon: urn:newsml:reuters.com:*:nGNX324fSj
Further company coverage: CBIO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Gyre Therapeutics
See all newsBrief: Gyre Therapeutics - Enters Employment Agreement With Ying Luo As CEO - SEC Filing
Gyre Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Gyre Therapeutics, Inc. expected to post a loss of 13 cents a share - Earnings Preview
Brief: Gyre Therapeutics Reports Second Quarter 2026
Gyre Therapeutics Q2 revenue beats estimates on higher ETUARY sales volumes